Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge-Reference-Cited by-同舟云学术

Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge

Published:2023-07-31 Issue:8 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Wang Yu¹,Zhao Danyang²,Xiao Wenying¹,Shi Jun¹,Chen Wei³,Jia Qin⁴,Zhou Ying⁵,Wang Rongyu⁶,Chen Xubo⁷,Feng Liuliu¹^ORCID

Affiliation:

1. Department of Cardiology, Shidong Hospital, Yangpu District Shidong Hospital Affiliated to University of Shanghai for Science and Technology Shanghai China

2. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

3. Department of Pharmacy, Shidong Hospital, Yangpu District Shidong Hospital Affiliated to University of Shanghai for Science and Technology Shanghai China

4. Department of Respiratory and Critical Care Medicine Shidong Hospital Affiliated to University of Shanghai for Science and Technology Shanghai China

5. Department of Geriatrics Shidong Hospital Affiliated to University of Shanghai for Science and Technology Shanghai China

6. Department of Cardiology Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital Shanghai China

7. Department of Rehabilitation Medicine, Shidong Hospital, Yangpu District Shidong Hospital affiliated to University of Shanghai for Science and Technology Shanghai China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29014

Reference23 articles.

1. AyoubkhaniD BosworthML KingS et al. Risk of Long Covid in people infected with SARS‐CoV‐2 after two doses of a COVID‐19 vaccine: community‐based matched cohort study. Paper presented at:Open Forum Infectious Diseases 2022.

2. Attributes and predictors of long COVID

3. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study

4. Post-acute COVID-19 syndrome

5. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis;Journal of Infection;2024-08

2. Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans;Clinical Microbiology and Infection;2024-08

3. The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-07

4. The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19;The Journal of Infectious Diseases;2024-05-20

5. Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization;International Journal of Infectious Diseases;2024-05